Vascular Function in Children with Low Birthweight and Its Relationship with Early Markers of Cardiovascular Risk

Claudio Joo Turoni1, Zulema Chaila, Rossana Chahla

  • 1Departamento Biomx00E9;dico-Fisiologx00ED;a, Facultad de Medicina, UNT, INSIBO-CONICET, Tucumx00E1;n, Argentina.

Insights

Low birthweight (LBW) is linked to early cardiovascular disease (CVD) risk. LBW children show impaired endothelial function, suggesting a need for early lifestyle interventions.

Area of Science:

  • Pediatrics
  • Cardiology
  • Metabolic Health

Background:

  • Low birthweight (LBW) is a known risk factor for developing cardiovascular diseases (CVD).
  • Limited research exists on the impact of LBW on early CVD markers in children.
  • Understanding these early changes is crucial for timely intervention.

Purpose of the Study:

  • To investigate endothelial function (EF) and arterial stiffness (AS) in children with LBW.
  • To examine the relationship between EF, AS, and early CVD risk factors in this population.

Main Methods:

  • A study involving 53 children with LBW (aged 4-6 years) and 33 controls.
  • Assessment of anthropometric, hemodynamic, and laboratory parameters (HOMA-IR, hs-CRP, adiponectin, leptin).
  • Evaluation of EF and AS using digital pulse plethysmography.

Main Results:

  • LBW children exhibited significantly augmented insulin, HOMA-IR, leptin, and hs-CRP levels compared to controls.
  • Endothelial function (EF) was significantly decreased in LBW children (37.5 ± 5.6%) versus controls (75.0 ± 11.9%).
  • Arterial stiffness (AS) showed no significant differences between groups; EF negatively correlated with waist circumference, leptin, hs-CRP, and cumulative CVD risk score.

Conclusions:

  • Children with LBW demonstrate altered endothelial function associated with early CVD risk factors.
  • Elevated metabolic and inflammatory markers suggest a pro-inflammatory state in LBW children.
  • Findings indicate a potential need for early lifestyle interventions to mitigate CVD risk.
Abstract

Related Concept Videos

Development of Blood Vessels01:07

Development of Blood Vessels

The development of the vascular system in a fetus is a complex and intricate process that begins as early as 15 to 16 days post-conception. This process starts outside the embryo, specifically in the mesoderm of the yolk sac, chorion, and connecting stalk. Approximately two days later, the formation of blood vessels occurs within the embryo itself.
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
1.8K
Vascular Resistance01:20

Vascular Resistance

Vascular resistance is a critical concept in understanding blood flow dynamics in the circulatory system. It refers to the resistance that blood encounters as it flows through the blood vessels. This resistance is a key factor in determining blood pressure and cardiac workload.
The primary determinants of vascular resistance are vessel diameter, blood viscosity, and vessel length. Among these, vessel diameter plays the most significant role due to the fourth power relationship described by...
12.7K
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
1.1K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.9K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
441
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
730